论文部分内容阅读
1 美国批准 Gleevec作为一线用药美国已批准诺华公司的抗癌药物 Gleevec(译注 :亦称Glivec) (通用名 :伊马替尼 ,imatinib)用作治疗早期慢性髓细胞样白血病 ( chronic myeloid leukaemia,CML)的一线药物 ,这是该药的新适应证。美国 FDA于 8月份优先审查了该药治疗早期 CML(慢?
1 United States Approves Gleevec for First-Line Use The United States has approved Novartis’s cancer drug Gleevec (generic name: imatinib) for the treatment of chronic myeloid leukemia (CML ) Of the first-line drugs, this is a new indication of the drug. US FDA prioritized in August the drug treatment of early CML (slow?